Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials
The package arrived cold and the ice packs were still solid at delivery, but the outer shipping box was not insulated
More than one trigger may be present
They have also been shown to reduce the rates of major adverse cardiovascular events, comprising non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death, in patients with type 2 diabetes mellitus
Patients can often maintain their weight loss with a lower dose after initial success, which can help balance effectiveness with tolerability. According to Lilly, both trials met their primary and all key secondary endpoints
For individuals with diabetes, a combined creatinine/cystatin C estimate of eGFR should be considered in settings where the creatinine-based eGFR may be unreliable for an individual (see Table 6) [21] [Grade D, Consensus]
